SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy -- Ignore unavailable to you. Want to Upgrade?

To: Todd A. Sinelli who wrote (96)2/23/1998 8:34:00 AM
From: deadstrait  Respond to of 184
 
The $60 price target is based on 1999 earnings estimate, with a PE of
40.

The $40 target was derived by using a PE of 26 on year 2000 earnings of
$2.97 per share and figuring in a discount rate of 38%.

Hope this helps. I don't have at hand how much of the company is held
by insiders. I will see what I can find out and if I do I will let you
know.

dead



To: Todd A. Sinelli who wrote (96)2/23/1998 10:35:00 AM
From: deadstrait  Read Replies (1) | Respond to of 184
 
I hope this will answer your questions. The following info was updated
as of Jan 31.

Institutional holdings 59%

Insider holdings are as follows:

D) Vincent Worms holds 960,000 shares
OD) Philipp Pouletty holds 224,000 shares
P) Dave Winter holds 4,700 shares
D) Fredrick Feldman holds 14,000 shares
D) Elizabeth Greetham holds 210,000 shares

Dead


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News